Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

59.92 -1.07 (-1.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,399,946
Open 62.22
Bid (Size) 57.88 (100)
Ask (Size) 59.92 (700)
Prev. Close 60.99
Today's Range 59.79 - 63.31
52wk Range 32.21 - 170.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 12, 2026) - Kahn Swick & Foti, LLC ("KSF")... 
Via Newsfile
Topics Fraud Lawsuit

Performance

YTD
-54.7%
-54.7%
1 Month
+51.7%
+51.7%
3 Month
-22.0%
-22.0%
6 Month
-61.4%
-61.4%
1 Year
-14.8%
-14.8%

More News

Read More
News headline image
WGS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Via Newsfile
Topics Fraud Lawsuit
News headline image
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Hedge Funder Eli Casdin Is Loading up on GeneDx Shares ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From SkyMedia, LLC
Via GlobeNewswire
News headline image
WGS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Via Newsfile
Topics Fraud Lawsuit
News headline image
GENEDX HOLDINGS CORP. (WGS) INVESTOR ALERT Investors With Large Losses in GeneDe Holdings Corp. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS
From Pomerantz LLP
Via GlobeNewswire
News headline image
WGS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GeneDx Holdings Corp. Securities Lawsuit - Contact Levi & Korsinsky
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Via Newsfile
Topics Fraud Lawsuit
News headline image
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
News headline image
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Investor Notice: Robbins LLP Informs Investors of the GeneDx Holdings Corp. Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Deadline on August 3, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
From GeneDx
Via Business Wire
News headline image
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗
Via The Motley Fool
Topics Artificial Intelligence

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 59.92
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 06/12/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.